Measuring hormone balance in saliva and blood for adrenal hyperplasia
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study measures hormone levels in your saliva and blood to better understand your body's daily rhythm. It aims to help doctors fine-tune your treatment for congenital adrenal hyperplasia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 6 years old.
- You must have a confirmed diagnosis of congenital adrenal hyperplasia (a condition where the body can't make enough cortisol).
- You must be currently taking glucocorticoid medication (like hydrocortisone) to treat the condition.
- You or your guardian must be able to understand French to receive study information.
- You must have no mouth sores or lesions that could affect saliva collection.
- You must be covered by a national health insurance or social security system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is building a reference range for a simple saliva test that measures cortisol, a hormone linked to stress and adrenal function. It may help diagnose conditions like Cushing's syndrome or adrenal insufficiency.
This early study tests Lu AG13909 in people with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. It aims to see how the drug affects hormone levels and whether it is safe for different CAH hormone patterns.
This study evaluates children (and sometimes relatives) who may have hormone (endocrine) or metabolism-related conditions. It helps doctors better understand these problems by doing a clinical evaluation.
This study tests a new medication for children with classic congenital adrenal hyperplasia (CAH). It aims to see if the drug helps better control hormone levels and reduce the need for high doses of current steroid medicines.
This study looks at the long-term experiences of adults with classic congenital adrenal hyperplasia (CAH), a condition affecting hormone production. It aims to understand patient satisfaction and health outcomes over time.
This study tracks adults with congenital adrenal hyperplasia (a condition where the body can't make enough cortisol) who switch to a new form of hydrocortisone called modified-release. It looks at how well the medication works over time and its effects on daily life.
Hear when a new Congenital Adrenal Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.